Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 30, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natera, Inc.
| 177 |
—
|
—
| +0.39% | 45.85K |
Jul 26
| |||||||
Rapport Therapeutics, Inc.
| 44.03K |
$24.52 | $1,079,575.36 | +63.27% | 113.63K |
Jul 1
| |||||||
Natera, Inc.
| 2.96K |
—
|
—
| +6.94% | 45.67K |
Jun 28
| |||||||
Bolt Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
Y-Mabs Therapeutics, Inc.
| 3.5K |
—
|
—
| +12.43% | 31.6K |
Jun 11
| |||||||
Rapport Therapeutics, Inc.
| 1.95M |
$17.00 | $9,500,008.00 |
∞
| 1.95M |
Jun 10
| |||||||
Rapport Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Natera, Inc.
| 210 |
—
|
—
| +0.49% | 42.71K |
Apr 26
| |||||||
Karuna Therapeutics, Inc.
| -1.41M |
$330.00 | -$466,830,870.00 | -100.00% |
0
|
Mar 18
| |||||||
Arrivent Biopharma, Inc.
| 1.7M |
$18.00 |
—
|
∞
| 1.7M |
Jan 30
| |||||||
Natera, Inc.
| 264 |
$63.79 | $16,840.56 | +0.63% | 42.5K |
Jan 26
| |||||||
Arrivent Biopharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Natera, Inc.
| -644.00K |
$58.75 | -$37,835,000.00 | -100.00% |
0
|
Dec 13
| |||||||
Natera, Inc.
| 396 |
$42.60 | $16,869.60 | +0.95% | 42.24K |
Oct 27
| |||||||
Natera, Inc.
| 328 |
$48.48 | $15,901.44 | +0.79% | 41.84K |
Jul 28
| |||||||
Natera, Inc.
| 2.75K |
—
|
—
| +7.09% | 41.51K |
Jun 30
| |||||||
Karuna Therapeutics, Inc.
| 990 |
—
|
—
| +3.05% | 33.49K |
Jun 20
| |||||||
Karuna Therapeutics, Inc.
| -391.98K |
—
|
—
| -22.11% | 1.38M |
Jun 14
| |||||||
Bolt Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
Y-Mabs Therapeutics, Inc.
| 2.33K |
—
|
—
| +9.04% | 28.11K |
Jun 8
| |||||||
Natera, Inc.
| 3.53K |
—
|
—
| +10.03% | 38.76K |
May 25
| |||||||
Natera, Inc.
| 285 |
$54.73 | $15,598.05 | +0.82% | 35.23K |
Apr 14
| |||||||
-6.11M |
$14.32 | -$85,920.00 | -100.00% |
0
|
Nov 28 - Feb 24
| ||||||||
Vera Therapeutics, Inc.
| 285.71K |
$7.00 | $1,999,998.00 | +8.98% | 3.47M |
Feb 6
| |||||||
Natera, Inc.
| 390 |
$40.01 | $15,603.90 | +1.13% | 34.94K |
Jan 13
| |||||||
Natera, Inc.
| -2.40K |
$37.71 | -$90,498.00 | -100.00% |
0
|
Nov 16
| |||||||
Karuna Therapeutics, Inc.
| -300.00K |
$199.90 | -$1,204,770.78 | -14.48% | 1.77M |
Jan 12 - Jan 13
| |||||||
Natera, Inc.
| 344 |
$45.42 | $15,624.48 | +1.01% | 34.55K |
Oct 14
| |||||||
Natera, Inc.
| 430 |
—
|
—
| +1.27% | 34.21K |
Jul 8
| |||||||
Cincor Pharma, Inc.
| 506K |
$30.00 | $15,180,000.00 | +9.08% | 6.08M |
Aug 11
| |||||||
Karuna Therapeutics, Inc.
| 32.5K |
$16.00 | $520,000.00 |
∞
| 32.5K |
Aug 5
| |||||||
Cincor Pharma, Inc.
| 29.41K |
$13.60 | $399,989.60 |
∞
| 29.41K |
Aug 5
| |||||||
Y-Mabs Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 15
| |||||||
Natera, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 8
| |||||||
Karuna Therapeutics, Inc.
| 120K |
$122.80 | $14,736,158.17 | +6.15% | 2.07M |
Jun 29 - Jun 30
| |||||||
Karuna Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Bolt Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Natera, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 27
| |||||||
Natera, Inc.
| 1.31K |
—
|
—
| +4.03% | 33.78K |
May 25
| |||||||
Karuna Therapeutics, Inc.
| 47 |
$129.38 | $6,080.86 | +7.39% | 683 |
Apr 1
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.